PharmaCom BioVet, Inc.
PharmaCom BioVet, Inc. PHMB Peers
See (PHMB) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHMB | $0.00 | +0.00% | 1.08M | N/A | N/A | N/A |
| FSNUY | $12.32 | -0.40% | 111.03B | 23.69 | $0.52 | N/A |
| RVLWF | $0.04 | +97.97% | 38.35B | -0.30 | -$0.13 | N/A |
| FSNUF | $37.73 | N/A | 21.25B | 18.05 | $2.09 | N/A |
| FMCQF | $57.26 | -7.41% | 16.80B | 24.26 | $2.36 | N/A |
| BDUUY | $32.33 | N/A | 12.84B | 28.36 | $1.14 | +2.79% |
| BDULF | $0.71 | N/A | 11.28B | 23.67 | $0.03 | +3.13% |
| JDHIY | $3.25 | +100.00% | 10.40B | 18.06 | $0.18 | N/A |
| JDHIF | $3.23 | N/A | 10.33B | 26.92 | $0.12 | N/A |
| IHHHF | $1.10 | -7.56% | 9.70B | 15.71 | $0.07 | +1.23% |
Stock Comparison
PHMB vs FSNUY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, FSNUY has a market cap of 111.03B. Regarding current trading prices, PHMB is priced at $0.00, while FSNUY trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FSNUY's P/E ratio is 23.69. In terms of profitability, PHMB's ROE is N/A, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, PHMB is more volatile compared to FSNUY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs RVLWF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, RVLWF has a market cap of 38.35B. Regarding current trading prices, PHMB is priced at $0.00, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, PHMB's ROE is N/A, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, PHMB is more volatile compared to RVLWF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs FSNUF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, FSNUF has a market cap of 21.25B. Regarding current trading prices, PHMB is priced at $0.00, while FSNUF trades at $37.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FSNUF's P/E ratio is 18.05. In terms of profitability, PHMB's ROE is N/A, compared to FSNUF's ROE of +0.02%. Regarding short-term risk, PHMB is more volatile compared to FSNUF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs FMCQF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, FMCQF has a market cap of 16.80B. Regarding current trading prices, PHMB is priced at $0.00, while FMCQF trades at $57.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FMCQF's P/E ratio is 24.26. In terms of profitability, PHMB's ROE is N/A, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, PHMB is more volatile compared to FMCQF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BDUUY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BDUUY has a market cap of 12.84B. Regarding current trading prices, PHMB is priced at $0.00, while BDUUY trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BDUUY's P/E ratio is 28.36. In terms of profitability, PHMB's ROE is N/A, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, PHMB is more volatile compared to BDUUY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BDULF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BDULF has a market cap of 11.28B. Regarding current trading prices, PHMB is priced at $0.00, while BDULF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BDULF's P/E ratio is 23.67. In terms of profitability, PHMB's ROE is N/A, compared to BDULF's ROE of +0.16%. Regarding short-term risk, PHMB is more volatile compared to BDULF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs JDHIY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, JDHIY has a market cap of 10.40B. Regarding current trading prices, PHMB is priced at $0.00, while JDHIY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JDHIY's P/E ratio is 18.06. In terms of profitability, PHMB's ROE is N/A, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, PHMB is more volatile compared to JDHIY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs JDHIF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, JDHIF has a market cap of 10.33B. Regarding current trading prices, PHMB is priced at $0.00, while JDHIF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JDHIF's P/E ratio is 26.92. In terms of profitability, PHMB's ROE is N/A, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, PHMB is more volatile compared to JDHIF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs IHHHF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, IHHHF has a market cap of 9.70B. Regarding current trading prices, PHMB is priced at $0.00, while IHHHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas IHHHF's P/E ratio is 15.71. In terms of profitability, PHMB's ROE is N/A, compared to IHHHF's ROE of +0.09%. Regarding short-term risk, PHMB is more volatile compared to IHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BDUUF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BDUUF has a market cap of 9.54B. Regarding current trading prices, PHMB is priced at $0.00, while BDUUF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BDUUF's P/E ratio is 20.00. In terms of profitability, PHMB's ROE is N/A, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, PHMB is more volatile compared to BDUUF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs RMYHY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, RMYHY has a market cap of 5.26B. Regarding current trading prices, PHMB is priced at $0.00, while RMYHY trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RMYHY's P/E ratio is 565.00. In terms of profitability, PHMB's ROE is N/A, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, PHMB is more volatile compared to RMYHY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs RMSYF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, RMSYF has a market cap of 5.06B. Regarding current trading prices, PHMB is priced at $0.00, while RMSYF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RMSYF's P/E ratio is 440.00. In terms of profitability, PHMB's ROE is N/A, compared to RMSYF's ROE of +0.18%. Regarding short-term risk, PHMB is more volatile compared to RMSYF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BUGDF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BUGDF has a market cap of 5.02B. Regarding current trading prices, PHMB is priced at $0.00, while BUGDF trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BUGDF's P/E ratio is 24.27. In terms of profitability, PHMB's ROE is N/A, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, PHMB is more volatile compared to BUGDF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs ANHGY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, ANHGY has a market cap of 4.05B. Regarding current trading prices, PHMB is priced at $0.00, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, PHMB's ROE is N/A, compared to ANHGY's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to ANHGY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BUHPF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BUHPF has a market cap of 3.86B. Regarding current trading prices, PHMB is priced at $0.00, while BUHPF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BUHPF's P/E ratio is 18.65. In terms of profitability, PHMB's ROE is N/A, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, PHMB is more volatile compared to BUHPF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs MCVEF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, MCVEF has a market cap of 2.99B. Regarding current trading prices, PHMB is priced at $0.00, while MCVEF trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MCVEF's P/E ratio is 86.22. In terms of profitability, PHMB's ROE is N/A, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, PHMB is more volatile compared to MCVEF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs ORPEF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, ORPEF has a market cap of 2.29B. Regarding current trading prices, PHMB is priced at $0.00, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, PHMB's ROE is N/A, compared to ORPEF's ROE of +0.91%. Regarding short-term risk, PHMB is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for PHMB.
PHMB vs TTALF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, TTALF has a market cap of 1.64B. Regarding current trading prices, PHMB is priced at $0.00, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas TTALF's P/E ratio is 19.33. In terms of profitability, PHMB's ROE is N/A, compared to TTALF's ROE of +0.15%. Regarding short-term risk, PHMB is more volatile compared to TTALF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs MCVEY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, MCVEY has a market cap of 1.58B. Regarding current trading prices, PHMB is priced at $0.00, while MCVEY trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MCVEY's P/E ratio is 52.54. In terms of profitability, PHMB's ROE is N/A, compared to MCVEY's ROE of +0.06%. Regarding short-term risk, PHMB is more volatile compared to MCVEY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs RYHTY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, RYHTY has a market cap of 1.47B. Regarding current trading prices, PHMB is priced at $0.00, while RYHTY trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RYHTY's P/E ratio is -20.71. In terms of profitability, PHMB's ROE is N/A, compared to RYHTY's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to RYHTY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs RHCGF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, RHCGF has a market cap of 1.43B. Regarding current trading prices, PHMB is priced at $0.00, while RHCGF trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RHCGF's P/E ratio is -20.14. In terms of profitability, PHMB's ROE is N/A, compared to RHCGF's ROE of -0.02%. Regarding short-term risk, PHMB is more volatile compared to RHCGF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs LWSCF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, LWSCF has a market cap of 1.20B. Regarding current trading prices, PHMB is priced at $0.00, while LWSCF trades at $12.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas LWSCF's P/E ratio is 44.79. In terms of profitability, PHMB's ROE is N/A, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, PHMB is more volatile compared to LWSCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs LTGHF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, LTGHF has a market cap of 1.18B. Regarding current trading prices, PHMB is priced at $0.00, while LTGHF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas LTGHF's P/E ratio is 11.70. In terms of profitability, PHMB's ROE is N/A, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, PHMB is more volatile compared to LTGHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs LTGHY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, LTGHY has a market cap of 1.15B. Regarding current trading prices, PHMB is priced at $0.00, while LTGHY trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas LTGHY's P/E ratio is 10.67. In terms of profitability, PHMB's ROE is N/A, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, PHMB is more volatile compared to LTGHY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs RAFLF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, RAFLF has a market cap of 1.11B. Regarding current trading prices, PHMB is priced at $0.00, while RAFLF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RAFLF's P/E ratio is 20.00. In terms of profitability, PHMB's ROE is N/A, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, PHMB is more volatile compared to RAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs RKAGY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, RKAGY has a market cap of 1.05B. Regarding current trading prices, PHMB is priced at $0.00, while RKAGY trades at $7.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RKAGY's P/E ratio is 23.09. In terms of profitability, PHMB's ROE is N/A, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, PHMB is more volatile compared to RKAGY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs RHKJF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, RHKJF has a market cap of 1.02B. Regarding current trading prices, PHMB is priced at $0.00, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, PHMB's ROE is N/A, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, PHMB is more volatile compared to RHKJF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs NWKHY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, NWKHY has a market cap of 950.53M. Regarding current trading prices, PHMB is priced at $0.00, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NWKHY's P/E ratio is 13.22. In terms of profitability, PHMB's ROE is N/A, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, PHMB is more volatile compared to NWKHY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs EXETF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, EXETF has a market cap of 859.71M. Regarding current trading prices, PHMB is priced at $0.00, while EXETF trades at $10.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas EXETF's P/E ratio is 16.35. In terms of profitability, PHMB's ROE is N/A, compared to EXETF's ROE of +0.66%. Regarding short-term risk, PHMB is more volatile compared to EXETF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs JXFGF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, JXFGF has a market cap of 755.56M. Regarding current trading prices, PHMB is priced at $0.00, while JXFGF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JXFGF's P/E ratio is 14.00. In terms of profitability, PHMB's ROE is N/A, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, PHMB is more volatile compared to JXFGF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs WHTCF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, WHTCF has a market cap of 754.11M. Regarding current trading prices, PHMB is priced at $0.00, while WHTCF trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas WHTCF's P/E ratio is -37.25. In terms of profitability, PHMB's ROE is N/A, compared to WHTCF's ROE of -0.03%. Regarding short-term risk, PHMB is more volatile compared to WHTCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs KDGTF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, KDGTF has a market cap of 675.13M. Regarding current trading prices, PHMB is priced at $0.00, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, PHMB's ROE is N/A, compared to KDGTF's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to KDGTF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs WFHG Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, WFHG has a market cap of 471.23M. Regarding current trading prices, PHMB is priced at $0.00, while WFHG trades at $7.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas WFHG's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to WFHG's ROE of +0.22%. Regarding short-term risk, PHMB is more volatile compared to WFHG. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs ORRRY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, ORRRY has a market cap of 371.54M. Regarding current trading prices, PHMB is priced at $0.00, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, PHMB's ROE is N/A, compared to ORRRY's ROE of +73.42%. Regarding short-term risk, PHMB is more volatile compared to ORRRY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BTMDW Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BTMDW has a market cap of 292.88M. Regarding current trading prices, PHMB is priced at $0.00, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, PHMB's ROE is N/A, compared to BTMDW's ROE of -0.19%. Regarding short-term risk, PHMB is more volatile compared to BTMDW. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs EVGRF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, EVGRF has a market cap of 235.44M. Regarding current trading prices, PHMB is priced at $0.00, while EVGRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas EVGRF's P/E ratio is -0.05. In terms of profitability, PHMB's ROE is N/A, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, PHMB is more volatile compared to EVGRF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs MKLNF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, MKLNF has a market cap of 224.32M. Regarding current trading prices, PHMB is priced at $0.00, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, PHMB's ROE is N/A, compared to MKLNF's ROE of +0.15%. Regarding short-term risk, PHMB is more volatile compared to MKLNF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs MFCSF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, MFCSF has a market cap of 215.92M. Regarding current trading prices, PHMB is priced at $0.00, while MFCSF trades at $11.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MFCSF's P/E ratio is 7.29. In terms of profitability, PHMB's ROE is N/A, compared to MFCSF's ROE of +0.84%. Regarding short-term risk, PHMB is more volatile compared to MFCSF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs CHHHF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, CHHHF has a market cap of 123.47M. Regarding current trading prices, PHMB is priced at $0.00, while CHHHF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas CHHHF's P/E ratio is -49.00. In terms of profitability, PHMB's ROE is N/A, compared to CHHHF's ROE of -0.05%. Regarding short-term risk, PHMB is more volatile compared to CHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs VTIAF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, VTIAF has a market cap of 104.42M. Regarding current trading prices, PHMB is priced at $0.00, while VTIAF trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas VTIAF's P/E ratio is -3.59. In terms of profitability, PHMB's ROE is N/A, compared to VTIAF's ROE of +0.11%. Regarding short-term risk, PHMB is more volatile compared to VTIAF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs MCIOF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, MCIOF has a market cap of 54.04M. Regarding current trading prices, PHMB is priced at $0.00, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, PHMB's ROE is N/A, compared to MCIOF's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to MCIOF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs ASSF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, ASSF has a market cap of 45.35M. Regarding current trading prices, PHMB is priced at $0.00, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ASSF's P/E ratio is -33.33. In terms of profitability, PHMB's ROE is N/A, compared to ASSF's ROE of -6.63%. Regarding short-term risk, PHMB is more volatile compared to ASSF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs KONEF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, KONEF has a market cap of 44.34M. Regarding current trading prices, PHMB is priced at $0.00, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas KONEF's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to KONEF's ROE of -6.56%. Regarding short-term risk, PHMB is more volatile compared to KONEF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs USNU Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, USNU has a market cap of 19.05M. Regarding current trading prices, PHMB is priced at $0.00, while USNU trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas USNU's P/E ratio is -7.42. In terms of profitability, PHMB's ROE is N/A, compared to USNU's ROE of -0.62%. Regarding short-term risk, PHMB is more volatile compared to USNU. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs HQDA Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, HQDA has a market cap of 18.64M. Regarding current trading prices, PHMB is priced at $0.00, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas HQDA's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to HQDA's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to HQDA. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs NVLPF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, NVLPF has a market cap of 16.21M. Regarding current trading prices, PHMB is priced at $0.00, while NVLPF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NVLPF's P/E ratio is 18.56. In terms of profitability, PHMB's ROE is N/A, compared to NVLPF's ROE of +0.08%. Regarding short-term risk, PHMB is more volatile compared to NVLPF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs FPCG Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, FPCG has a market cap of 10.25M. Regarding current trading prices, PHMB is priced at $0.00, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FPCG's P/E ratio is 0.09. In terms of profitability, PHMB's ROE is N/A, compared to FPCG's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to FPCG. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs XCRT Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, XCRT has a market cap of 8.65M. Regarding current trading prices, PHMB is priced at $0.00, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas XCRT's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to XCRT's ROE of +2.48%. Regarding short-term risk, PHMB is more volatile compared to XCRT. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs NUMIF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, NUMIF has a market cap of 8.32M. Regarding current trading prices, PHMB is priced at $0.00, while NUMIF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NUMIF's P/E ratio is -0.42. In terms of profitability, PHMB's ROE is N/A, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, PHMB is more volatile compared to NUMIF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs HLYK Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, HLYK has a market cap of 5.60M. Regarding current trading prices, PHMB is priced at $0.00, while HLYK trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas HLYK's P/E ratio is -0.99. In terms of profitability, PHMB's ROE is N/A, compared to HLYK's ROE of +2.41%. Regarding short-term risk, PHMB is more volatile compared to HLYK. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BICX Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BICX has a market cap of 5.15M. Regarding current trading prices, PHMB is priced at $0.00, while BICX trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BICX's P/E ratio is -0.78. In terms of profitability, PHMB's ROE is N/A, compared to BICX's ROE of +0.40%. Regarding short-term risk, PHMB is more volatile compared to BICX. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs VLXC Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, VLXC has a market cap of 5.01M. Regarding current trading prices, PHMB is priced at $0.00, while VLXC trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas VLXC's P/E ratio is -7.00. In terms of profitability, PHMB's ROE is N/A, compared to VLXC's ROE of +0.68%. Regarding short-term risk, PHMB is more volatile compared to VLXC. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs GBCS Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, GBCS has a market cap of 4.63M. Regarding current trading prices, PHMB is priced at $0.00, while GBCS trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas GBCS's P/E ratio is -1.89. In terms of profitability, PHMB's ROE is N/A, compared to GBCS's ROE of +0.56%. Regarding short-term risk, PHMB is more volatile compared to GBCS. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs RHEP Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, RHEP has a market cap of 4.47M. Regarding current trading prices, PHMB is priced at $0.00, while RHEP trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RHEP's P/E ratio is -0.98. In terms of profitability, PHMB's ROE is N/A, compared to RHEP's ROE of +1.29%. Regarding short-term risk, PHMB is more volatile compared to RHEP. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs GRST Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, GRST has a market cap of 3.09M. Regarding current trading prices, PHMB is priced at $0.00, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas GRST's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to GRST's ROE of +0.30%. Regarding short-term risk, PHMB is more volatile compared to GRST. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs EPWCF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, EPWCF has a market cap of 2.54M. Regarding current trading prices, PHMB is priced at $0.00, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas EPWCF's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, PHMB and EPWCF have similar daily volatility (196.04).
PHMB vs JRSS Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, JRSS has a market cap of 1.90M. Regarding current trading prices, PHMB is priced at $0.00, while JRSS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JRSS's P/E ratio is -0.37. In terms of profitability, PHMB's ROE is N/A, compared to JRSS's ROE of +2.63%. Regarding short-term risk, PHMB is more volatile compared to JRSS. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs TOKIF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, TOKIF has a market cap of 1.78M. Regarding current trading prices, PHMB is priced at $0.00, while TOKIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas TOKIF's P/E ratio is -0.01. In terms of profitability, PHMB's ROE is N/A, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, PHMB and TOKIF have similar daily volatility (196.04).
PHMB vs SMAS Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, SMAS has a market cap of 1.46M. Regarding current trading prices, PHMB is priced at $0.00, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SMAS's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to SMAS's ROE of N/A. Regarding short-term risk, PHMB and SMAS have similar daily volatility (196.04).
PHMB vs MDGP Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, MDGP has a market cap of 1.45M. Regarding current trading prices, PHMB is priced at $0.00, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MDGP's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to MDGP's ROE of -2.19%. Regarding short-term risk, PHMB is more volatile compared to MDGP. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs NOVC Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, NOVC has a market cap of 1.16M. Regarding current trading prices, PHMB is priced at $0.00, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NOVC's P/E ratio is -0.20. In terms of profitability, PHMB's ROE is N/A, compared to NOVC's ROE of +0.12%. Regarding short-term risk, PHMB is more volatile compared to NOVC. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs GNOW Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, GNOW has a market cap of 859731.00. Regarding current trading prices, PHMB is priced at $0.00, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas GNOW's P/E ratio is -0.01. In terms of profitability, PHMB's ROE is N/A, compared to GNOW's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to GNOW. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs DPAT Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, DPAT has a market cap of 397353.00. Regarding current trading prices, PHMB is priced at $0.00, while DPAT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas DPAT's P/E ratio is -1.65. In terms of profitability, PHMB's ROE is N/A, compared to DPAT's ROE of +0.45%. Regarding short-term risk, PHMB is more volatile compared to DPAT. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs KJFI Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, KJFI has a market cap of 374580.00. Regarding current trading prices, PHMB is priced at $0.00, while KJFI trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas KJFI's P/E ratio is -0.06. In terms of profitability, PHMB's ROE is N/A, compared to KJFI's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to KJFI. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs NXGT Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, NXGT has a market cap of 369855.00. Regarding current trading prices, PHMB is priced at $0.00, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NXGT's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to NXGT's ROE of +0.09%. Regarding short-term risk, PHMB is more volatile compared to NXGT. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs SETO Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, SETO has a market cap of 343035.00. Regarding current trading prices, PHMB is priced at $0.00, while SETO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SETO's P/E ratio is -2.75. In terms of profitability, PHMB's ROE is N/A, compared to SETO's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to SETO. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs ARPC Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, ARPC has a market cap of 336555.00. Regarding current trading prices, PHMB is priced at $0.00, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ARPC's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to ARPC's ROE of -0.56%. Regarding short-term risk, PHMB is more volatile compared to ARPC. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs FCHS Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, FCHS has a market cap of 197750.00. Regarding current trading prices, PHMB is priced at $0.00, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FCHS's P/E ratio is -0.05. In terms of profitability, PHMB's ROE is N/A, compared to FCHS's ROE of +0.12%. Regarding short-term risk, PHMB is more volatile compared to FCHS. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs JNHMF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, JNHMF has a market cap of 165397.00. Regarding current trading prices, PHMB is priced at $0.00, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JNHMF's P/E ratio is -0.07. In terms of profitability, PHMB's ROE is N/A, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, PHMB is more volatile compared to JNHMF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs HSMD Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, HSMD has a market cap of 153388.00. Regarding current trading prices, PHMB is priced at $0.00, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas HSMD's P/E ratio is -0.05. In terms of profitability, PHMB's ROE is N/A, compared to HSMD's ROE of -0.04%. Regarding short-term risk, PHMB is more volatile compared to HSMD. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BNYN Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BNYN has a market cap of 150549.00. Regarding current trading prices, PHMB is priced at $0.00, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BNYN's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to BNYN's ROE of -14.10%. Regarding short-term risk, PHMB and BNYN have similar daily volatility (196.04).
PHMB vs CLRD Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, CLRD has a market cap of 140705.00. Regarding current trading prices, PHMB is priced at $0.00, while CLRD trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas CLRD's P/E ratio is -0.01. In terms of profitability, PHMB's ROE is N/A, compared to CLRD's ROE of +0.38%. Regarding short-term risk, PHMB is more volatile compared to CLRD. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs TPIA Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, TPIA has a market cap of 113827.00. Regarding current trading prices, PHMB is priced at $0.00, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas TPIA's P/E ratio is -0.15. In terms of profitability, PHMB's ROE is N/A, compared to TPIA's ROE of +0.61%. Regarding short-term risk, PHMB is more volatile compared to TPIA. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs COLRF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, COLRF has a market cap of 108333.00. Regarding current trading prices, PHMB is priced at $0.00, while COLRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas COLRF's P/E ratio is -0.01. In terms of profitability, PHMB's ROE is N/A, compared to COLRF's ROE of +0.02%. Regarding short-term risk, PHMB is more volatile compared to COLRF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs AMBD Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, AMBD has a market cap of 85625.00. Regarding current trading prices, PHMB is priced at $0.00, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas AMBD's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to AMBD's ROE of +1.11%. Regarding short-term risk, PHMB and AMBD have similar daily volatility (196.04).
PHMB vs NMHLY Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, NMHLY has a market cap of 41741.00. Regarding current trading prices, PHMB is priced at $0.00, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, PHMB's ROE is N/A, compared to NMHLY's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to NMHLY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs GENN Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, GENN has a market cap of 32696.00. Regarding current trading prices, PHMB is priced at $0.00, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas GENN's P/E ratio is -0.02. In terms of profitability, PHMB's ROE is N/A, compared to GENN's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to GENN. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs DRWN Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, DRWN has a market cap of 23978.00. Regarding current trading prices, PHMB is priced at $0.00, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas DRWN's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to DRWN's ROE of -0.01%. Regarding short-term risk, PHMB is more volatile compared to DRWN. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs SCAL Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, SCAL has a market cap of 17424.00. Regarding current trading prices, PHMB is priced at $0.00, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SCAL's P/E ratio is 0.04. In terms of profitability, PHMB's ROE is N/A, compared to SCAL's ROE of +0.07%. Regarding short-term risk, PHMB is more volatile compared to SCAL. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs CHCR Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, CHCR has a market cap of 11991.00. Regarding current trading prices, PHMB is priced at $0.00, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas CHCR's P/E ratio is -0.00. In terms of profitability, PHMB's ROE is N/A, compared to CHCR's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to CHCR. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs NAFS Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, NAFS has a market cap of 10510.00. Regarding current trading prices, PHMB is priced at $0.00, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NAFS's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to NAFS's ROE of +1.02%. Regarding short-term risk, PHMB is more volatile compared to NAFS. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs ACGI Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, ACGI has a market cap of 10477.00. Regarding current trading prices, PHMB is priced at $0.00, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ACGI's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to ACGI's ROE of +1.11%. Regarding short-term risk, PHMB is more volatile compared to ACGI. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs CEVE Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, CEVE has a market cap of 7709.00. Regarding current trading prices, PHMB is priced at $0.00, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas CEVE's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to CEVE's ROE of +2.26%. Regarding short-term risk, PHMB is more volatile compared to CEVE. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs PRMD Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, PRMD has a market cap of 5610.00. Regarding current trading prices, PHMB is priced at $0.00, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas PRMD's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to PRMD's ROE of +0.73%. Regarding short-term risk, PHMB is more volatile compared to PRMD. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs MSGP Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, MSGP has a market cap of 5191.00. Regarding current trading prices, PHMB is priced at $0.00, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MSGP's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to MSGP's ROE of +0.27%. Regarding short-term risk, PHMB is more volatile compared to MSGP. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs MSITF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, MSITF has a market cap of 4800.00. Regarding current trading prices, PHMB is priced at $0.00, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MSITF's P/E ratio is -0.00. In terms of profitability, PHMB's ROE is N/A, compared to MSITF's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to MSITF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs ERUC Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, ERUC has a market cap of 3915.00. Regarding current trading prices, PHMB is priced at $0.00, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ERUC's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to ERUC's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to ERUC. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs SLHPF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, SLHPF has a market cap of 3901.00. Regarding current trading prices, PHMB is priced at $0.00, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SLHPF's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, PHMB and SLHPF have similar daily volatility (196.04).
PHMB vs WEQL Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, WEQL has a market cap of 3534.00. Regarding current trading prices, PHMB is priced at $0.00, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas WEQL's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to WEQL's ROE of +0.21%. Regarding short-term risk, PHMB is more volatile compared to WEQL. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BBAL Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BBAL has a market cap of 3354.00. Regarding current trading prices, PHMB is priced at $0.00, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BBAL's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to BBAL's ROE of +0.45%. Regarding short-term risk, PHMB is more volatile compared to BBAL. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs PAOG Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, PAOG has a market cap of 2478.00. Regarding current trading prices, PHMB is priced at $0.00, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas PAOG's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to PAOG's ROE of +0.08%. Regarding short-term risk, PHMB is more volatile compared to PAOG. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs NMMCF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, NMMCF has a market cap of 2087.00. Regarding current trading prices, PHMB is priced at $0.00, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, PHMB's ROE is N/A, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to NMMCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs PPRG Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, PPRG has a market cap of 1580.00. Regarding current trading prices, PHMB is priced at $0.00, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas PPRG's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to PPRG's ROE of -0.58%. Regarding short-term risk, PHMB is more volatile compared to PPRG. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs OHAQ Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, OHAQ has a market cap of 1375.00. Regarding current trading prices, PHMB is priced at $0.00, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, PHMB's ROE is N/A, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, PHMB is more volatile compared to OHAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs BNKL Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, BNKL has a market cap of 1248.00. Regarding current trading prices, PHMB is priced at $0.00, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BNKL's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to BNKL's ROE of -7.69%. Regarding short-term risk, PHMB is more volatile compared to BNKL. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs MAHN Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, MAHN has a market cap of 1211.00. Regarding current trading prices, PHMB is priced at $0.00, while MAHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MAHN's P/E ratio is 0.05. In terms of profitability, PHMB's ROE is N/A, compared to MAHN's ROE of N/A. Regarding short-term risk, PHMB and MAHN have similar daily volatility (196.04).
PHMB vs SLHGF Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, SLHGF has a market cap of 398.00. Regarding current trading prices, PHMB is priced at $0.00, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SLHGF's P/E ratio is -0.00. In terms of profitability, PHMB's ROE is N/A, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to SLHGF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs LHRP Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, LHRP has a market cap of 340.00. Regarding current trading prices, PHMB is priced at $0.00, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas LHRP's P/E ratio is 0.00. In terms of profitability, PHMB's ROE is N/A, compared to LHRP's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to LHRP. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.
PHMB vs NMSCA Comparison
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.08M. In comparison, NMSCA has a market cap of 275.00. Regarding current trading prices, PHMB is priced at $0.00, while NMSCA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NMSCA's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to NMSCA's ROE of +0.02%. Regarding short-term risk, PHMB is more volatile compared to NMSCA. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.